These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24222772)

  • 1. Perspectives on the use of stem cells for autism treatment.
    Siniscalco D; Bradstreet JJ; Sych N; Antonucci N
    Stem Cells Int; 2013; 2013():262438. PubMed ID: 24222772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell therapy in autism: recent insights.
    Siniscalco D; Kannan S; Semprún-Hernández N; Eshraghi AA; Brigida AL; Antonucci N
    Stem Cells Cloning; 2018; 11():55-67. PubMed ID: 30425534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells in treating autism: Novel insights.
    Siniscalco D; Bradstreet JJ; Sych N; Antonucci N
    World J Stem Cells; 2014 Apr; 6(2):173-8. PubMed ID: 24772244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.
    Liu Q; Chen MX; Sun L; Wallis CU; Zhou JS; Ao LJ; Li Q; Sham PC
    World J Stem Cells; 2019 Feb; 11(2):55-72. PubMed ID: 30842805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic role of hematopoietic stem cells in autism spectrum disorder-related inflammation.
    Siniscalco D; Bradstreet JJ; Antonucci N
    Front Immunol; 2013; 4():140. PubMed ID: 23772227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?
    Siniscalco D; Sapone A; Cirillo A; Giordano C; Maione S; Antonucci N
    J Biomed Biotechnol; 2012; 2012():480289. PubMed ID: 22496609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of dietary bioactive proteins and peptides in autism spectrum disorders.
    Siniscalco D; Antonucci N
    Curr Protein Pept Sci; 2013 Dec; 14(8):674-9. PubMed ID: 24106964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible use of Trichuris suis ova in autism spectrum disorders therapy.
    Siniscalco D; Antonucci N
    Med Hypotheses; 2013 Jul; 81(1):1-4. PubMed ID: 23597946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.
    ;
    MMWR Surveill Summ; 2012 Mar; 61(3):1-19. PubMed ID: 22456193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing disrupted neurodevelopment in autism using human stem cell-derived neurons and organoids: An outlook into future diagnostics and drug development.
    Yang G; Shcheglovitov A
    Dev Dyn; 2020 Jan; 249(1):6-33. PubMed ID: 31398277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia as possible therapeutic targets for autism spectrum disorders.
    Andoh M; Ikegaya Y; Koyama R
    Prog Mol Biol Transl Sci; 2019; 167():223-245. PubMed ID: 31601405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.
    Bradstreet JJ; Sych N; Antonucci N; Klunnik M; Ivankova O; Matyashchuk I; Demchuk M; Siniscalco D
    Cell Transplant; 2014; 23 Suppl 1():S105-12. PubMed ID: 25302490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in Gene Expression in Autism Spectrum Disorders: An Extensive Review of Transcriptomic Studies.
    Ansel A; Rosenzweig JP; Zisman PD; Melamed M; Gesundheit B
    Front Neurosci; 2016; 10():601. PubMed ID: 28105001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of iPSC technology for modeling Autism Spectrum Disorders.
    Russo FB; Brito A; de Freitas AM; Castanha A; de Freitas BC; Beltrão-Braga PCB
    Neurobiol Dis; 2019 Oct; 130():104483. PubMed ID: 31129084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceuticals and Stem Cells in Autism Spectrum Disorders: Wishful Thinking?
    Sivanesan S; Tan A; Jeyaraj R; Lam J; Gole M; Hardan A; Ashkan K; Rajadas J
    World Neurosurg; 2017 Feb; 98():659-672. PubMed ID: 27725300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Derived Stem Cells, Another
    Maussion G; Rocha C; Bernard G; Beitel LK; Durcan TM
    Front Pediatr; 2019; 7():225. PubMed ID: 31245336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The autism spectrum phenotype in ADNP syndrome.
    Arnett AB; Rhoads CL; Hoekzema K; Turner TN; Gerdts J; Wallace AS; Bedrosian-Sermone S; Eichler EE; Bernier RA
    Autism Res; 2018 Sep; 11(9):1300-1310. PubMed ID: 30107084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological interventions in autism spectrum disorder.
    Politte LC; Henry CA; McDougle CJ
    Harv Rev Psychiatry; 2014; 22(2):76-92. PubMed ID: 24614763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Practice and Future Avenues in Autism Therapy.
    Poustka L; Kamp-Becker I
    Curr Top Behav Neurosci; 2017; 30():357-378. PubMed ID: 27130325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell-Derived Exosomes in Autism Spectrum Disorder.
    Alessio N; Brigida AL; Peluso G; Antonucci N; Galderisi U; Siniscalco D
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.